122 related articles for article (PubMed ID: 1672362)
1. Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamide.
Brown JM; Lemmon MJ; Horsman MR; Lee WW
Int J Radiat Biol; 1991 Mar; 59(3):739-48. PubMed ID: 1672362
[TBL] [Abstract][Full Text] [Related]
2. Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.
Horsman MR; Brown DM; Lemmon MJ; Brown JM; Lee WW
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1307-10. PubMed ID: 2944859
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
Horsman MR
Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
[TBL] [Abstract][Full Text] [Related]
4. Comparison of low dose nicotinamide versus benzamide, administered per os, as radiosensitizers in a C3H mammary carcinoma.
Kjellen E; Pero RW; Nilsson P
Radiother Oncol; 1988 Aug; 12(4):327-31. PubMed ID: 2973086
[TBL] [Abstract][Full Text] [Related]
5. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
Chaplin DJ; Horsman MR; Siemann DW
Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing.
Horsman MR; Siemann DW; Chaplin DJ; Overgaard J
Radiother Oncol; 1997 Nov; 45(2):167-74. PubMed ID: 9424008
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization by nicotinamide in vivo: a greater enhancement of tumor damage compared to that of normal tissues.
Horsman MR; Chaplin DJ; Brown JM
Radiat Res; 1987 Mar; 109(3):479-89. PubMed ID: 2951765
[TBL] [Abstract][Full Text] [Related]
8. Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation.
Horsman MR; Chaplin DJ; Brown JM
Radiat Res; 1989 Apr; 118(1):139-50. PubMed ID: 2523079
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status.
Horsman MR; Hansen PV; Overgaard J
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1273-6. PubMed ID: 2523883
[TBL] [Abstract][Full Text] [Related]
10. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
Rojas A; Smith KA; Soranson JA; Minchinton AI; Middleton RW; Denekamp J
Radiother Oncol; 1984 Dec; 2(4):325-32. PubMed ID: 6522642
[TBL] [Abstract][Full Text] [Related]
12. The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo.
Horsman MR; Wood PJ; Chaplin DJ; Brown JM; Overgaard J
Radiother Oncol; 1990 May; 18(1):49-57. PubMed ID: 2141694
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Brown JM; Yu NY; Workman P
Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
[TBL] [Abstract][Full Text] [Related]
19. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
Brown JM
Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
[No Abstract] [Full Text] [Related]
20. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Horsman MR; Overgaard J
Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
